Monroe Capital Corporation is a business development company specializing in senior, unitranche and junior secured debt and to a lesser extent, unsecured debt and equity investments, and buyouts in middle-market companies. The fund prefers to invest in casinos and gaming, broadcasting, publishing, alcoholic beverage and tobacco distribution, oil and gas, insurance, pharmaceuticals and bio sciences, aerospace and defense, commercial printing, natural rubber, glass, container and packaging, metals and mining, and real estate. It focuses to invest in the United States and Canada. The fund focuses on companies with a maximum of $25 million in EBITDA per year.
Industry, Sector and Symbol
Industry Investment advice
Sub-IndustryN/A
SectorFinance
Phone312-258-8300
Debt
Price-To-Earnings
Sales & Book Value
Annual Sales$51.11 million
Profitability
Miscellaneous
EmployeesN/A
OptionableOptionable
Monroe Capital (NASDAQ:MRCC) Frequently Asked Questions
What is Monroe Capital's stock symbol?
Monroe Capital trades on the NASDAQ under the ticker symbol "MRCC."
How often does Monroe Capital pay dividends? What is the dividend yield for Monroe Capital?
Monroe Capital announced a quarterly dividend on Monday, December 3rd. Shareholders of record on Friday, December 14th will be given a dividend of $0.35 per share on Friday, December 28th. This represents a $1.40 dividend on an annualized basis and a yield of 11.25%. The ex-dividend date is Thursday, December 13th. View Monroe Capital's Dividend History.
How were Monroe Capital's earnings last quarter?
Monroe Capital Corp (NASDAQ:MRCC) released its earnings results on Tuesday, November, 6th. The financial services provider reported $0.38 earnings per share (EPS) for the quarter, topping the Zacks' consensus estimate of $0.36 by $0.02. The financial services provider earned $13.78 million during the quarter, compared to analysts' expectations of $15.36 million. Monroe Capital had a return on equity of 11.44% and a net margin of 12.15%. View Monroe Capital's Earnings History.
When is Monroe Capital's next earnings date?
What price target have analysts set for MRCC?
5 equities research analysts have issued twelve-month price objectives for Monroe Capital's shares. Their predictions range from $12.50 to $13.00. On average, they anticipate Monroe Capital's share price to reach $12.8333 in the next twelve months. This suggests a possible upside of 3.2% from the stock's current price. View Analyst Price Targets for Monroe Capital.
What is the consensus analysts' recommendation for Monroe Capital?
5 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Monroe Capital in the last year. There are currently 4 hold ratings and 1 buy rating for the stock, resulting in a consensus recommendation of "Hold." View Analyst Ratings for Monroe Capital.
What are Wall Street analysts saying about Monroe Capital stock?
Here are some recent quotes from research analysts about Monroe Capital stock:
- 1. National Securities analysts commented, " Monroe earned adjusted NII/share of $0.38 for 3Q18, two cents above our estimate and three cents above the quarterly dividend. However, the earnings beat came from the incentive fee not being earned at all during the quarter, which we model to have positively impacted earnings by $0.07/share.
The incentive fee was not earned due to NAV/share declining to $12.97 from $13.35 Q/Q. The decrease in NAV came as a result from realized losses on the equity in Rockdale and Millennial Brands. Gibson was also sold for a realized loss on an accounting basis, but Monroe made a cash-on-cash return on the investment overall.
In July, Rockdale Blackhawk entered chapter 11. This was and still is one of Monroe’s largest portfolio companies, representing 3.7% of the portfolio at cost as of 6/30/18 and 3.8% at 9/30/18. The equity was sold for a loss (although it had a zero cost-basis some of the loan costs were attributed to it) and the loans were written down and placed on non-accrual.
Our biggest issue, and the primary one that moves us to the sidelines with a neutral rating, is the lack of transparency surrounding this investment. Rockdale filed for bankruptcy in July, yet this was not discussed on the earnings call. While we could understand Monroe being comfortable with recovery prospects, marks, asset coverage, and the overall outcome, we cannot fathom why this was not announced given we certainly feel it is a material event.
The market is more likely to now apply a much steeper discount on a go-forward basis for MRCC as it factors in the potential of not having the full picture with regards to portfolio health, as we see it. The market can look past credit issues for a great platform, in our opinion, but will have a harder time looking past trust and uncertainty, in our opinion.
We are revising our 2018 adjusted NII/share estimate to $1.58 from $1.54 and our 2019 adjusted NII/share estimate to $1.50 from $1.58. Our earnings estimates are higher for 2018 as we don’t expect the incentive fee to be earned at all in 4Q18 & 1Q19. " (11/9/2018)
- 2. According to Zacks Investment Research, "Monroe Capital Corporation is a non-diversified closed-end management investment company focused on providing financing primarily to lower middle-market companies in the United States and Canada. The Company's investment objective is to maximize the total return to its stockholders in the form of current income and capital appreciation through investments in senior, unitranche and junior secured debt and unsecured debt and equity investments. Monroe Capital Corporation is headquartered in Chicago. " (11/9/2018)
Has Monroe Capital been receiving favorable news coverage?
Press coverage about MRCC stock has been trending neutral recently, InfoTrie Sentiment Analysis reports. InfoTrie identifies positive and negative media coverage by reviewing more than six thousand news and blog sources in real time. The firm ranks coverage of publicly-traded companies on a scale of -5 to 5, with scores closest to five being the most favorable. Monroe Capital earned a coverage optimism score of 0.3 on InfoTrie's scale. They also assigned news articles about the financial services provider a news buzz of 5.0 out of 10, meaning that recent media coverage is somewhat likely to have an impact on the company's share price in the immediate future.
Who are some of Monroe Capital's key competitors?
Some companies that are related to Monroe Capital include PJT Partners (PJT), Victory Capital (VCTR), Virtus Investment Partners (VRTS), Och-Ziff Capital Management Group (OZM), Pzena Investment Management (PZN), Diamond Hill Investment Group (DHIL), Barings BDC (BBDC), Fidus Investment (FDUS), Westwood Holdings Group (WHG), Silvercrest Asset Management Group (SAMG), Value Line (VALU), Saratoga Investment (SAR), StoneCastle Financial (BANX), Alcentra Capital (ABDC) and Great Elm Capital (GECC).
Who are Monroe Capital's key executives?
Monroe Capital's management team includes the folowing people:
- Mr. Theodore L. Koenig, Chairman, Pres & CEO (Age 60)
- Mr. Aaron D. Peck, Chief Investment Officer, CFO & Director (Age 48)
- Mr. David H. Jacobson, Chief Compliance Officer (Age 58)
Who are Monroe Capital's major shareholders?
Monroe Capital's stock is owned by a variety of of institutional and retail investors. Top institutional investors include Advisors Asset Management Inc. (1.15%), Cliffwater LLC (1.06%), Van ECK Associates Corp (0.81%), Janney Montgomery Scott LLC (0.70%), Commonwealth Equity Services LLC (0.70%) and CIBC Private Wealth Group LLC (0.57%). Company insiders that own Monroe Capital stock include Aaron Daniel Peck, Jeffrey A Golman, Jeffrey D Steele, Robert S Rubin and Theodore L Koenig. View Institutional Ownership Trends for Monroe Capital.
Which institutional investors are selling Monroe Capital stock?
MRCC stock was sold by a variety of institutional investors in the last quarter, including Raymond James & Associates, Stephens Inc. AR, WESPAC Advisors LLC, Chicago Partners Investment Group LLC, Rothschild Investment Corp IL, Janney Montgomery Scott LLC, Sumitomo Mitsui Asset Management Company LTD and Advisors Asset Management Inc.. View Insider Buying and Selling for Monroe Capital.
Which institutional investors are buying Monroe Capital stock?
MRCC stock was purchased by a variety of institutional investors in the last quarter, including Freestone Capital Holdings LLC, West Family Investments Inc., Wiley BROS. Aintree Capital LLC, Commonwealth Equity Services LLC, Stifel Financial Corp, Two Sigma Investments LP, CFO4Life Group LLC and Oppenheimer & Co. Inc.. Company insiders that have bought Monroe Capital stock in the last two years include Aaron Daniel Peck, Jeffrey A Golman, Jeffrey D Steele, Robert S Rubin and Theodore L Koenig. View Insider Buying and Selling for Monroe Capital.
How do I buy shares of Monroe Capital?
Shares of MRCC can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.
What is Monroe Capital's stock price today?
One share of MRCC stock can currently be purchased for approximately $12.44.
How big of a company is Monroe Capital?
Monroe Capital has a market capitalization of $254.34 million and generates $51.11 million in revenue each year. The financial services provider earns $12.15 million in net income (profit) each year or $1.40 on an earnings per share basis.
What is Monroe Capital's official website?
How can I contact Monroe Capital?
Monroe Capital's mailing address is 311 SOUTH WACKER DRIVE SUITE 6400, CHICAGO IL, 60606. The financial services provider can be reached via phone at 312-258-8300 or via email at [email protected]
MarketBeat Community Rating for Monroe Capital (NASDAQ MRCC)
MarketBeat's community ratings are surveys of what our community members think about Monroe Capital and other stocks. Vote "Outperform" if you believe MRCC will outperform the S&P 500 over the long term. Vote "Underperform" if you believe MRCC will underperform the S&P 500 over the long term. You may vote once every thirty days.
